Eli Lilly has poached a rising star from Bristol Myers Squibb’s hematology marketing unit to become the next chief commercial officer for its oncology division, Loxo@Lilly. Winselow Tucker will assume ...
After heading up Bristol Myers Squibb's worldwide commercial immuno-oncology melanoma and genitourinary unit, Erik Johnson is parting ways to help launch miR Scientific's first product. Johnson is ...
Bristol Myers Squibb (BMS) plans to buy out its partner in developing the blockbuster multiple myeloma drug Abecma ® (idecabtagene vicleucel), by agreeing to acquire 2seventy bio for approximately ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results